Skip to main content
Clinical Trials/JPRN-UMIN000041193
JPRN-UMIN000041193
Completed
未知

Changes in the factors associated with the renal prognosis during 12 months before and after administration of luseogliflozin in patients with type 2 diabetes - Changes in the factors associated with the renal prognosis during 12 months before and after administration of luseogliflozin in patients with type 2 diabetes

Department of Diabetes, Metabolism and Kidney Disease,Edogawa Hospital0 sites238 target enrollmentJuly 22, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
diabetes mellitus
Sponsor
Department of Diabetes, Metabolism and Kidney Disease,Edogawa Hospital
Enrollment
238
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 22, 2020
End Date
June 30, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Diabetes, Metabolism and Kidney Disease,Edogawa Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects with replacement from other SGLT2 inhibitors or GLP\-1 receptor antagonists, those with observation period less than 12 months, those with change of diuretics or anti\-hypertensive agents during the observation period and those with add\-on of GLP\-1 receptor antagonists during the observation period

Outcomes

Primary Outcomes

Not specified

Similar Trials